What is the prevalence of Wilms Tumor?

Wilms tumor, also known as nephroblastoma, is a rare form of kidney cancer that primarily affects children, with an annual incidence of approximately 1 in 10,000 children under the age of 15. While it is the most common primary renal neoplasm in childhood, it is still considered a rare disease, and accurate global prevalence is difficult to track due to variations in healthcare access and diagnostic reporting.

How common is Wilms tumor globally?

Wilms tumor is classified as a rare pediatric malignancy. In the United States, the National Institutes of Health (NIH) GARD estimates that it accounts for about 5% to 6% of all childhood cancers. Because Wilms tumor is generally treated and cured within a specific window of childhood, the "prevalence" (total number of people currently living with the disease) is lower than the "incidence" (number of new cases per year), which is roughly 500 new cases annually in the U.S. alone.

What are the demographic patterns of Wilms tumor?

The distribution of Wilms tumor shows specific trends regarding age and biology:

• Age of onset: The median age at diagnosis is approximately 3 to 4 years old. Cases in adults are exceptionally rare.


• Gender distribution: There is a slight female predominance in some studies, but overall, Wilms tumor affects males and females at nearly equal rates.


• Ethnic variations: Epidemiological data indicates a higher incidence rate among African American children compared to Caucasian children, while Asian populations typically show lower rates.

Why is gathering accurate data on Wilms tumor challenging?

Although Wilms tumor is well-studied in clinical oncology, gathering exact prevalence data is complicated by the fact that many cases are associated with underlying genetic syndromes (such as WAGR or Denys-Drash syndrome). Furthermore, while rare, some cases may go undiagnosed in regions with limited access to pediatric imaging, meaning current statistics may slightly underestimate the true global burden. At DiseaseMaps.org, we have 18 community members who have shared their experiences with Wilms tumor, providing a vital, real-world perspective that complements clinical data.

Next steps

• Consult a pediatric oncologist or a specialist in pediatric urology for diagnostic confirmation.


• Connect with the Wilms tumor community at DiseaseMaps.org to share experiences with other families.


• Review resources from the National Wilms Tumor Study Group (NWTSG) for the latest clinical trial information.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Wilms tumor overview.


• Orphanet: Nephroblastoma (ORPHA:914).


• OMIM (Online Mendelian Inheritance in Man): Entry #194070 regarding genetic predisposition.


• American Cancer Society: Statistics for Kidney Cancer in Children.